Number of crystalloid fluid boluses, median (IQR)
| | | |
Totala
| | | |
Prior to randomization
| | | |
During intervention phase
| | | |
Crystalloid volume administered (mL/kg), median (IQR)
| | | |
Total fluid (bolus and maintenance)a
| | | |
Any crystalloid
| | | |
0.9% saline
| | | |
Balanced/buffered fluid
| | | |
Bolus fluid only
| | | |
Prior to randomization
| | | |
During intervention phase
| | | |
0.9% saline
| | | |
Balanced/buffered fluid
| | | |
Maintenance fluid only
| | | |
Any crystalloid
| | | |
0.9% saline
| | | |
Balanced/buffered fluid
| | | |
Other
| | | |
Colloid volume administered (mL/kg), median (IQR)
| | | |
Albumin 4%/5%
| | | |
Other
| | | |
Blood product volume administered (mL/kg), median (IQR)
| | | |
Red blood cells
| | | |
Platelets
| | | |
Plasma or cryoprecipitate
| | | |
Other
| | | |
Fluid volume categoriesa, n (%)
| | | |
Total crystalloid (bolus and maintenance)
| | | |
<60 mL/kg
| | | |
60–100 mL/kg
| | | |
>100 mL/kg
| | | |
Bolus fluid only
| | | |
<60 mL/kg
| | | |
60–100 mL/kg
| | | |
>100 mL/kg
| | | |
Protocol Adherence
| | | |
Received ≥75% of total crystalloid as randomized fluid type during intervention phase, n (%)
| | | |